Back to Test Catalogue

Aripiprazole, Serum/Plasma

Test ID: ARIP
Test
Specimen
Performance / Interpretation
Interface / Setup

Test

Aliases/Synonyms

Abilify®

Method

Chromatography/Mass Spectrometry

Report Includes

Aripiprazole

Specimens

Avoid gel separator tubes; Serum; Plasma (EDTA)

Clinical Utility

Aripiprazole (Abilify®) is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. The analysis of aripiprazole is used to monitor compliance with drug therapy.

Test Version

19-Jan-2023

Specimen

Specimens

Avoid gel separator tubes; Serum; Plasma (EDTA)

Collection Containers

Preferred

Red top (no additive)

Acceptable

Lavender top (EDTA)

Sample Volume

3 mL

Minimum Volume

0.5 mL

Specimen Comment

Avoid gel separator tubes.

Collection & Handling

Handling Information

Store and send cold or frozen.

Stability

Ambient 7 days
Refrigerated 14 days
Frozen 30 days

Rejection Criteria

Specimen Gel-separator tube

Test Version

19-Jan-2023

Performance / Interpretation

Method

Chromatography/Mass Spectrometry

Turnaround Time

9 days

Results

Name Units Reference Range Conversion Factor
Aripirazole ng/mL
  • See comment below

Steady state plasma levels in adults following a daily regimen have been reported as:

  • 5 mg 70 to 126
  • 10 mg 109 to 216
  • 15 mg 206 to 278
  • 20 mg 212 to 574
  • 30 mg 320 to 585

Test Version

19-Jan-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
ARIP 63006 ARIPIPRAZOLE, QN, SERUM/PLASMA ng/mL

Test Version

19-Jan-2023